Beverly Hills Cancer Center — Beverly Hills, California

Beverly Hills Cancer Center is a clinical research site located in Beverly Hills, California, United States 90211.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Beverly Hills Cancer Center has participated in 63 clinical trials with 26 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Lung Cancer, Non-small Cell Lung Cancer.

Sponsors: G1 Therapeutics, Inc., Eli Lilly and Company, Elevation Oncology.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beverly Hills Cancer Center?

Beverly Hills Cancer Center has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beverly Hills Cancer Center conducted?

Beverly Hills Cancer Center has 63 clinical trials on record, with 26 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Lung Cancer, Non-small Cell Lung Cancer.

Is Beverly Hills Cancer Center accredited by Crixeo Health?

Beverly Hills Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beverly Hills Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.